Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Immunological imaging using tagged octreotide].

G L Cascini1, V Cuccurullo, P F Rambaldi

  • 1Medicina Nucleare, Dipartimento di Internistica Clinica Sperimentale F. Magrassi-A. Lanzara, Seconda Università degli Studi, Naples, Italy.

Minerva Endocrinologica
|December 26, 2001
PubMed
Summary

Radiolabeled octreotide scintigraphy is effective for diagnosing neuroendocrine tumors due to strong receptor correlation. This imaging technique also shows promise in other conditions, including Graves' ophthalmopathy and thymic hyperplasia in children.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Correction: Thymic hyperplasia is accurate to detect new-onset Graves' hyperthyroidism and resolves after restoring euthyroidism.

Journal of endocrinological investigation·2025
Same author

Thymic hyperplasia is accurate to detect new-onset Graves' hyperthyroidism and resolves after restoring euthyroidism.

Journal of endocrinological investigation·2024
Same author

The presence of senescent peripheral T-cells is negatively correlated to COVID-19 vaccine-induced immunity in cancer patients under 70 years of age.

Frontiers in immunology·2023
Same author

Does type of immunosupression influence the course of Covid-19 infection?

The Journal of infection·2020
Same author

Systemic high-dose intravenous methotrexate in patients with central nervous system metastatic breast cancer.

BMC cancer·2019
Same author

Longitudinal cognitive decline in mild cognitive impairment subjects with early amyloid-β neocortical deposition.

European journal of nuclear medicine and molecular imaging·2019

Area of Science:

  • Nuclear Medicine
  • Oncology
  • Endocrinology

Background:

  • Somatostatin receptor scintigraphy with radiolabeled octreotide is established for neuroendocrine neoplasms.
  • Octreotide uptake occurs in various pathologies due to receptor expression on lymphocytes, fibroblasts, and endothelium.

Purpose of the Study:

  • To explore the diagnostic and potential therapeutic applications of octreotide scintigraphy beyond neuroendocrine tumors.
  • To evaluate the role of octreotide scintigraphy in conditions like Graves' ophthalmopathy and pediatric thymic hyperplasia.

Main Methods:

  • Utilizing radiolabeled octreotide for somatostatin receptor scintigraphy.
  • Correlating in vitro receptor expression with in vivo radiotracer uptake.
  • Investigating octreotide uptake in diverse cell types and pathological conditions.

Related Experiment Videos

Main Results:

  • Successful diagnostic use in neuroendocrine neoplasms with good in vitro-in vivo correlation.
  • Demonstrated octreotide uptake in various pathologies involving lymphocytes, fibroblasts, and endothelium.
  • Showcased potential applications in Graves' ophthalmopathy and pediatric thymic hyperplasia post-chemotherapy.

Conclusions:

  • Somatostatin receptor scintigraphy with octreotide offers valuable diagnostic insights in neuroendocrine tumors.
  • Expanding applications include immunological imaging in other diseases, such as Graves' ophthalmopathy and thymic conditions.
  • Octreotide scintigraphy presents promising diagnostic, prognostic, and therapeutic prospects, even if not yet routinely applied in all fields.